Evidence map›Paper›PMID 27046148›Full record

ArticlePloS one2016

Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in Mice.

Charles E Bane, Ivan Ivanov, Anton Matafonov, Kelli L Boyd, Qiufang Cheng, Edward R Sherwood, Erik I Tucker, Stephen T Smiley, Owen J T McCarty, Andras Gruber and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. What to expect from drug targeting factor XI?Cardiovascular research · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Charles E BaneDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, United States of America.
Ivan IvanovDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, United States of America.
Anton MatafonovDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, United States of America.
Kelli L BoydDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, United States of America.
Qiufang ChengDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, United States of America.
Edward R SherwoodDepartment of Anesthesiology, Vanderbilt University, Nashville, Tennessee, United States of America.
Erik I TuckerAronora, Inc., Portland, Oregon, United States of America.
Stephen T SmileyNational Institute of Allergy and Infectious Disease, Bethesda, Maryland, United States of America.
Owen J T McCartyDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, United States of America.
Andras GruberAronora, Inc., Portland, Oregon, United States of America.
David GailaniDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, United States of America.
Vanderbilt University · USOregon Health & Science University · USAronora (United States) · USNational Institute of Allergy and Infectious Diseases · US

Funding

Characterization of Coagulation Factor-platelet Interactions: Role of FXIR01HL101972 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Owen J McCarty · 2010 to 2026
$8.5M
Physiology and Molecular Biology of Factor XIR01HL058837 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAILANI, DAVID · 1997 to 2017
$6.4M
Factor Xl in Vascular ThrombosisR01HL081326 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GAILANI, DAVID · 2007 to 2017
$3.5M
FXI and SepsisR01GM116184 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LUPU, FLOREA, MCCARTY, OWEN J · 2015 to 2018
$1.9M
NHLBI NIH HHS HL58837NHLBI NIH HHS HL81326NHLBI NIH HHS R01 HL058837NHLBI NIH HHS R01 HL081326NHLBI NIH HHS R01 HL101972NIGMS NIH HHS GM116184NIGMS NIH HHS R01 GM116184
6 · The paper itself

Abstract

Sepsis, a systemic inflammatory response to infection, is often accompanied by abnormalities of blood coagulation. Prior work with a mouse model of sepsis induced by cecal ligation and puncture (CLP) suggested that the protease factor XIa contributed to disseminated intravascular coagulation (DIC) and to the cytokine response during sepsis. We investigated the importance of factor XI to cytokine and coagulation responses during the first 24 hours after CLP. Compared to wild type littermates, factor XI-deficient (FXI-/-) mice had a survival advantage after CLP, with smaller increases in plasma levels of TNF-α and IL-10 and delayed IL-1β and IL-6 responses. Plasma levels of serum amyloid P, an acute phase protein, were increased in wild type mice 24 hours post-CLP, but not in FXI-/- mice, supporting the impression of a reduced inflammatory response in the absence of factor XI. Surprisingly, there was little evidence of DIC in mice of either genotype. Plasma levels of the contact factors factor XII and prekallikrein were reduced in WT mice after CLP, consistent with induction of contact activation. However, factor XII and PK levels were not reduced in FXI-/- animals, indicating factor XI deficiency blunted contact activation. Intravenous infusion of polyphosphate into WT mice also induced changes in factor XII, but had much less effect in FXI deficient mice. In vitro analysis revealed that factor XIa activates factor XII, and that this reaction is enhanced by polyanions such polyphosphate and nucleic acids. These data suggest that factor XI deficiency confers a survival advantage in the CLP sepsis model by altering the cytokine response to infection and blunting activation of the contact (kallikrein-kinin) system. The findings support the hypothesis that factor XI functions as a bidirectional interface between contact activation and thrombin generation, allowing the two processes to influence each other.

Indexed as

AnimalsCoinfectionCytokinesEnzyme ActivationFactor XI DeficiencyMicePeptide HydrolasesSepsisCytokinesPeptide Hydrolases

Identifiers

PMID27046148
PMCPMC4821616
OpenAlexW2313919223

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.